Raymond James Financial Services Advisors’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-9,090
Closed -$1.2M – 2907
2018
Q4
$1.2M Sell
9,090
-6,617
-42% -$848K 0.01% 1167
2018
Q3
$2.1M Buy
15,707
+6,628
+73% +$993K 0.01% 1046
2018
Q2
$1.45M Sell
9,079
-7
-0.1% -$1.04K 0.01% 1202
2018
Q1
$1.3M Sell
9,086
-159
-2% -$21.7K 0.01% 1162
2017
Q4
$1.23M Buy
+9,245
New +$1.18M 0.01% 1177
2017
Q3
– Sell
-3,902
Closed -$548K – 2659
2017
Q2
$548K Buy
+3,902
New +$487K ﹤0.01% 1627
2016
Q3
– Sell
-1,925
Closed -$266K – 2419
2016
Q2
$266K Buy
1,925
+472
+32% +$62.4K ﹤0.01% 1795
2016
Q1
$202K Buy
+1,453
New +$199K ﹤0.01% 1760

Raymond James Financial Services Advisors's ATHN Position: Q1 2019 in Review

Raymond James Financial Services Advisors sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 9,090 shares — an estimated $1.2M sold.

Raymond James Financial Services Advisors first reported a position in ATHN in Q1 2016 and held it in 8 quarters. The position peaked at $2.1M in Q3 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • Raymond James Financial Services Advisors reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 9,090 Athenahealth, Inc. shares in Q1 2019, an estimated $1.2M.
  • Raymond James Financial Services Advisors first reported a position in Athenahealth, Inc. in Q1 2016 and held it in 8 quarters.
  • Raymond James Financial Services Advisors's Athenahealth, Inc. position peaked at $2.1M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2019, filed 6 May 2019.